Exclusive: Japan’s Mitsui Sells Its Entire Equity Stake In India’s Arch Pharma
This article was originally published in PharmAsia News
Executive Summary
Mitsui, the Japanese conglomerate, is believed to have sold its equity stake in Arch Pharma. The deal was concluded amicably but the conditions imposed by financial institutions to agree to a debt restructuring proposal may have been a factor for an untimely exit.